Recursion Pharmaceuticals' year-to-date stock performance.
Recursion Pharmaceuticals: "I am, myself, confounded by it. The stock has been horrendous...So I do not like to recommend horrendous stocks."

watch now
Sign up now for the CNBC Investing Club to follow Jim Cramer's every move in the market.
Questions for Cramer?
Call Cramer: 1-800-743-CNBC
Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram
Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com

